Notice of Completion of PMDA’s 14-Day Review Period for the TMS-008 Phase IIa Clinical Trial
Filed with TSE · · 2 pages · English
Story so far
Earlier from TMS
- Notice of Submission of a Clinical Trial Plan Notification for a Phase IIa Clinical Trial of TMS-008 for Acute Kidney Injury
- (Correction) Notice of Partial Correction to “Presentation Materials”
- Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
- Mindful Health Solutions Advances Patient Experience with Sohar Health's Verification Solution
Follow TMS into a list and get an email when it puts out news.
Follow TMS